Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Transplantation

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1097/TP.0000000000000717PMID 25905982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic biomarkers correlate with HLA-identical renal transplant tolerance.

  2013cited by this paper
• Successful resolution of inflammation and increased regulatory T cells in sirolimus‐treated post‐transplant allograft hepatitis

  2012cited by this paper
• Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells

  2011cited by this paper
• Moving to tolerance: clinical application of T regulatory cells.

  2011cited by this paper
• IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer

  2011cited by this paper
• Generation and Large‐Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft‐Versus‐Host Disease

  2011cited by this paper
• IL-2 Controls the Stability of Foxp3 Expression in TGF-β–Induced Foxp3+ T Cells In Vivo

  2011cited by this paper
• Low-Dose Antigen Promotes Induction of FOXP3 in Human CD4+ T Cells

  2011cited by this paper
• Human regulatory T cells in autoimmune diseases.

  2010cited by this paper
• Enhancement of antigen-specific Treg vaccination in vivo

  2010cited by this paper
• Inflammatory Effects of Ex Vivo Human Th17 Cells Are Suppressed by Regulatory T Cells

  2010cited by this paper
• An update on regulatory T cells in transplant tolerance and rejection

  2010cited by this paper
• IL-17– and IFN-γ–Secreting Foxp3+ T Cells Infiltrate the Target Tissue in Experimental Autoimmunity

  2010cited by this paper
• Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells

  2010influential reference
• New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression

  2010cited by this paper
• Th17 and regulatory T cells in mediating and restraining inflammation.

  2010cited by this paper
• Allospecific Regulatory Effects of Sirolimus and Tacrolimus in the Human Mixed Lymphocyte Reaction

  2010influential reference
• TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo

  2010cited by this paper
• Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective

  2009cited by this paper
• Recently discovered T cell subsets cannot keep their commitments.

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• Early and Limited Use of Tacrolimus to Avoid Rejection in an Alemtuzumab and Sirolimus Regimen for Kidney Transplantation: Clinical Results and Immune Monitoring

  2009cited by this paper
• IL-1beta and IL-2 convert human Treg into T(H)17 cells.

  2009cited by this paper
• Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

  2009cited by this paper
• The T helper 17–regulatory T cell axis in transplant rejection and tolerance

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• Faculty Opinions recommendation of IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.

  2008cited by this paper
• Critical role of IL‐2 and TGF‐β in generation, function and stabilization of Foxp3+CD4+ Treg

  2008cited by this paper
• IL-21 and TGF-β are required for differentiation of human TH17 cells

  2008cited by this paper
• T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

  2008cited by this paper
• Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.

  2008cited by this paper
• FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans

  2008cited by this paper
• Regulation of IL-17 in Human CCR6+ Effector Memory T Cells1

  2008cited by this paper
• Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.

  2008cited by this paper
• Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

  2008cited by this paper
• Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells

  2007cited by this paper
• Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1

  2007cited by this paper
• Mycophenolate Mofetil/Sirolimus Compared to Other Common Immunosuppressive Regimens in Kidney Transplantation

  2007cited by this paper
• DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells

  2007cited by this paper
• Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells

  2007cited by this paper
• IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

  2007cited by this paper
• Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes

  2007cited by this paper
• FOXP3 controls regulatory T cell function through cooperation with NFAT.

  2006influential reference
• Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

  2006cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Non‐Classical Pathways of Cell‐Mediated Allograft Rejection: New Challenges for Tolerance Induction?

  2003cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1996influential reference
• Immunopharmacology of rapamycin.

  1996cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992cited by this paper

• Cellular Therapies in Transplantation – Regulatory T Cell Therapies and Virus Specific Therapies

  2025cites this paper
• SpiDe-Sr: blind super-resolution network for precise cell segmentation and clustering in spatial proteomics imaging

  2024influential citation
• Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

  2024cites this paper
• Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells

  2024cites this paper
• Pretransplant, Th17 dominant alloreactivity in highly sensitized kidney transplant candidates

  2024cites this paper
• Targeting TFH cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an in vitro and in vivo study

  2023cites this paper
• mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro

  2023cites this paper
• The immunomodulation role of Th17 and Treg in renal transplantation

  2023cites this paper
• Peanut allergy in an adult following cardiac transplant from a non-atopic donor.

  2023cites this paper
• Tacrolimus before CTLA4Ig and rapamycin promotes vascularized composite allograft survival in MGH miniature swine.

  2022cites this paper
• mTORC1 Inhibition Protects Human Regulatory T Cells From Granzyme-B-Induced Apoptosis

  2022cites this paper
• Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

  2022cites this paper
• Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation

  2021cites this paper
• Novel Immunomodulatory Approaches for Porcine Islet Xenotransplantation

  2021cites this paper
• Deep phenotyping of T cell populations under long‐term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry

  2021cites this paper
• Expansion and characterization of regulatory T cell populations from Korean kidney transplant recipients

  2021cites this paper
• CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to Success

  2021cites this paper
• Plasticity of Treg and imbalance of Treg/Th17 cells in patients with systemic sclerosis modified by FK506

  2021cites this paper
• A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy

  2021cites this paper
• Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

  2021cites this paper
• Limited efficacy of rapamycin monotherapy in vascularized composite allotransplantation.

  2020cites this paper
• Regulatory T-cell therapy in Crohn’s disease: challenges and advances

  2020cites this paper
• mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28− Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection

  2020cites this paper
• Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil

  2019cites this paper
• Tacrolimus inhibits Th1 and Th17 responses in MuSK‐antibody positive myasthenia gravis patients

  2019cites this paper
• Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion inhibits RORγt T-bet expression in kidney transplantation.

  2019cites this paper
• Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study.

  2019cites this paper
• Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients

  2019cites this paper
• Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol.

  2019cites this paper
• Plant Enzymes Decrease Prostate Cancer Cell Numbers and Increase TNF-α In Vivo: A Possible Role in Immunostimulatory Activity

  2019cites this paper
• T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation.

  2019cites this paper
• Cell therapeutic approaches to immunosuppression after clinical kidney transplantation

  2018cites this paper
• A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants

  2018cites this paper
• Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance

  2018cites this paper
• Effect of induction therapy on circulating T‐helper 17 and T‐regulatory cells in active proliferative lupus nephritis

  2018cites this paper
• Sirolimus vs mycophenolate moftile in Tacrolimus based therapy after induction with Antithymocyte globulin promote regulatory T cell expansion and inhibit RORγt and T-bet expression in kidney transplantation

  2018cites this paper
• Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner

  2018cites this paper
• Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis

  2018cites this paper
• Promising effect of rapamycin on multiple sclerosis.

  2018cites this paper
• Regulatory T Cells and Kidney Transplantation.

  2018cites this paper
• Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.

  2018cites this paper
• Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells

  2017cites this paper
• The Immune Response to the Allograft

  2017cites this paper
• Regulatory T Cell Therapy in Transplantation

  2017cites this paper
• Impact of immunosuppressive drugs on circulating Tfh cells in kidney transplant recipients: A pilot study.

  2017cites this paper
• T Follicular Helper Cells As a New Target for Immunosuppressive Therapies

  2017cites this paper
• Suppression of Th17-polarized airway inflammation by rapamycin

  2017cites this paper
• Different in vitro proliferation and cytokine‐production inhibition of memory T‐cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment

  2016cites this paper
• Impact of Immune-Modulatory Drugs on Regulatory T Cell

  2016cites this paper
• Mycobacterium Chlorophenolicum Isolation in Sirolimus-Associated Pneumonitis

  2016cites this paper
• Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses

  2016cites this paper
• FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients

  2016cites this paper
• Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells

  2015cites this paper
• Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• Cell therapy for immunosuppression after kidney transplantation

  2015cites this paper